Login / Signup

Humoral antibody response to the first dose of the ChAdOx1 nCoV-19 vaccine in Asian patients undergoing hemodialysis.

Kuei-Ting TungYu-Sen PengShih-Ping HsuHon-Yen WuYen-Ling ChiuJu-Yeh YangMei-Fen PaiKai-Hsiang ShuSzu-Yu PanHui-Ming LuWan-Yu LinChun-Hsing LiaoFang-Yeh ChuWan-Chuan Tsai
Published in: Hemodialysis international. International Symposium on Home Hemodialysis (2022)
In Asian hemodialysis patients, the seropositive rate was low, and most had low antibody titers after the first dose of the ChAdOx1 nCoV-19 vaccine. Younger age, better dialysis adequacy, and higher albumin levels were associated with seropositivity.
Keyphrases
  • patients undergoing
  • chronic kidney disease
  • end stage renal disease
  • immune response
  • peritoneal dialysis